Immunosuppressant doses are tapered after transplantation to reduce infection risks
Immunosuppressant doses, particularly corticosteroids, are routinely tapered or withdrawn following organ transplantation to minimize long-term adverse events and metabolic complications without increasing rejection risks.
The claim is specific and empirical, addressing the clinical practice of tapering immunosuppression after organ transplantation. Multiple peer-reviewed sources confirm that steroid minimization, tapering, or withdrawal protocols are implemented to decrease drug toxicity and associated health risks, thereby supporting the claim.
Minato C, Nasri A, Noly PE, Boulet J, Parent MC, Fortier A, de Denus S, Tremblsay-Gravel M, Giraldeau G, Lamarche Y, Ducharme A. Rapid Corticosteroid Withdrawal After Cardiac Transplantation Improves Outcomes.. 2025. https://doi.org/10.1111/ctr.70420
Rapid corticosteroid withdrawal protocols reduce overall drug-related complications, including infection rates, following heart transplantation.
See more details
Knioła E, Foroncewicz B, Lerut J, Pączek L, Mucha K. Induction of Clinical Operational Tolerance Through Immunosuppression Minimization: Less Is More?. 2026. https://doi.org/10.1111/liv.70659
Minimizing and withdrawing immunosuppression steps down cumulative drug-related risks and side effects without compromising graft function.
Lee H, Choi Y, Suh HS. The Clinical Impact of Early Steroid Withdrawal on Diabetes Mellitus After Liver Transplantation: A Population-Based Cohort Study.. 2026. https://doi.org/10.3389/ti.2026.15432
Early steroid tapering and withdrawal within the first three months post-transplant successfully mitigates metabolic complications such as diabetes mellitus.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt